Milind Deshpande - Insider Trading & Ownership

Entity
Individual
Location
Achillion Pharmaceuticals, 300 George Street, New Haven, CT
Summary
The estimated net worth of Milind Deshpande is at least $104K dollars as of May 30, 2024. Milind Deshpande is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $104K.
All Insider Reports
All Insider Reports

Ownership of Milind Deshpande

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SPRO Spero Therapeutics, Inc. Director $104K May 29, 2024

Insider Transactions Reported by Milind Deshpande:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.